Female Genital Tuberculosis, Ghana: A Case Report Authors: Anthony K Dah, Dennis Brempong, Paschal K Dah, Gladys Kaba, Emily Boakye‐Yiadom, Ernest Kwasi Adjei, Verner N Orish Published: 2026 ABSTRACT ABSTRACTFemale genital tuberculosis is an underdiagnosed cause of infertility and amenorrhea in tuberculosis‐endemic regions. Hysteroscopy combined with histopathology can confirm the diagnosis even when molecular testing is negative. Clinicians should maintain a high index of suspicion and pursue multimodal diagnostic evaluation in women with unexplained infertility.Keywords: amenorrhea, female genital tuberculosis, GeneXpert, Ghana, hysteroscopy, infertility Introduction Female genital tuberculosis (FG‐TB) is an important but often overlooked cause of infertility [1]. However, there is paucity of epidemiological and clinical data on FG‐TB [2]. Thus, FG‐TB prevalence remains difficult to estimate because patients remain asymptomatic and undiagnosed [3]. Reports in developed countries like USA, Australia and Western European countries suggested an incidence of less than 1% in developed countries but up to 15%–19% in developing countries, specifically 17% and 6%–21% in Nigeria and South Africa respectively [4]. FG‐TB is usually spread hematogenously from the lungs or through lymphatic circulation or directly through contiguous organs like the bowels to the genital regions of females [5]. Diagnosis remains challenging due to the paucibacillary nature of genital specimens and the limited sensitivity of microscopy and culture [6]. As a result, hysteroscopy and histopathology are crucial instruments for recognizing necrotizing granulomatous inflammation and detecting distinctive intrauterine alterations [7]. In Ghana, reports of female genital tuberculosis remain scarce, and documentation of hysteroscopic diagnosis is virtually absent. This case report highlights the need for increased clinical suspicion in tuberculosis‐endemic areas. A systematic literature search of published case reports from Ghana yielded no similar cases, and we therefore present what is, to the best of our knowledge, the first published case report of female genital tuberculosis diagnosed via hysteroscopy and histopathology in Ghana. Case Report Case History and Assessment A 36‐year‐old nulliparous female married for 5 years reported to a private fertility center, Ho, Volta region with a 5‐year history of infertility and chronic pelvic pain. She also reported recurrent post‐coital bleeding and a 2‐year history of thick creamy discharge. Her menstrual history revealed an earlier regular cycle (28–32 days) with a gradual reduction in flow over several years, subsequently leading to secondary amenorrhea for 2 years. She previously received unsuccessful treatment with combined oral contraceptives and herbal preparations. She also reported prolonged close contact with a relative diagnosed with pulmonary tuberculosis but had no symptoms suggestive of active pulmonary tuberculosis. Differential Diagnosis, Investigations and Treatment Laboratory investigations, including a full blood count, hepatitis B surface antigen testing, a Venereal Disease Research Laboratory test, and fasting blood glucose measurement, were all within normal limits. Transvaginal ultrasound was unremarkable. High vaginal and endocervical swabs grew Citrobacter species sensitive to ceftriaxone, gentamicin, and amikacin. Hysteroscopy revealed an inflamed cervix, mild cervical canal adhesions, extensive necrotic cotton‐like material replacing the endometrium, peripheral intrauterine adhesions, and bilateral tubal ostial obstruction (Figure 1 and Figure 2). Histopathological examination of endometrial biopsy specimens demonstrated necrotizing granulomatous inflammation with central caseous necrosis surrounded by epithelioid cells and Langhans giant cells consistent with tuberculosis (Figure 3 and Figure 4). Sputum evaluation or chest radiography was not done as there were no clinical symptoms and signs pointing to pulmonary tuberculosis. Hysteroscopy illustrating uterine cavity containing necrotic tissues before treatment. Hysteroscopy illustrating uterine cavity containing necrotic tissues before treatment. Histology of endometrial biopsies consistent with tuberculosis related granulomatous inflammation; showing numerous epithelioid histiocytes (elongated, pale cytoplasm cells), scattered lymphocytes with areas that look like amorphous eosinophilic (pink) material suggestive of necrosis. Granuloma with central caseous necrosis surrounded by epithelioid cells and Langhans giant cells. Based on hysteroscopic findings and histopathology, a diagnosis of female genital tuberculosis was made. A GeneXpert MTB/RIF assay (Cepheid, Sunnyvale, CA) was performed on an endometrial biopsy specimen and returned a negative result for Mycobacterium tuberculosis . The patient was commenced on a nine‐month anti‐tuberculosis regimen in accordance with the Ghana National Tuberculosis Control Programme guidelines, comprising an intensive phase of two months of 4 tablets of fixed dose combination of 75 mg isoniazid, 150 mg rifampicin, 400 mg pyrazinamide, and 275 mg ethambutol (2HRZE), followed by a continuation phase of seven months of 4 tablets of fixed dose combination of 75 mg isoniazid and 150 mg rifampicin (7HR). The patient tolerated the regimen and reported clinical improvement during the course of treatment. The patient was also given IV ceftriaxone 2 g daily for 7 days. Outcome and Follow‐Up She experienced intermittent vaginal spotting during treatment, suggesting partial restoration of endometrial function. Repeat hysteroscopy at 8 months revealed: Repeat hysteroscopy at eight months demonstrated a normal‐appearing cervix, residual peripheral intrauterine adhesions, complete absence of necrotic tissue, and persistent bilateral tubal obstruction (Figure 5 and Figure 6). Panoramic view of the uterine cavity with no necrotic tissue after treatment. Bare fundal region of uterine cavity with no necrotic tissue or significant endometrium after treatment. Follow‐up histology indicated less well‐formed granulomas with necrosis not very prominent and fragments of endometrial stroma infiltrated by a dense chronic inflammatory cell population composed predominantly of lymphocytes and plasma cells (Figure 7 and Figure 8). Post‐treatment cervical smear showed complete resolution of inflammation and no intraepithelial lesions. An enhanced micrograph demonstrating less well‐formed granulomas with necrosis not very prominent after 8 months of treatment. Fragments of endometrial stroma infiltrated by a dense chronic inflammatory cell population composed predominantly of lymphocytes and plasma cells with poorly formed granulomas after treatment. Patient and her partner were counseled on in vitro fertilization and child adoption due to reduced fertility potential. She was also placed on Oestradiol Velerate and Progesterone to support endometrial growth and menstruation. Discussion Female genital tuberculosis (FG‐TB) remains a significant but unrecognized contributor to infertility, especially in areas with elevated tuberculosis incidence. This case's non‐specific clinical presentation highlights the complexity of the condition's diagnosis and treatment, reflecting larger trends reported in the literature. As shown in our case, the condition predominantly affects women of reproductive age and frequently manifests as nonspecific symptoms including irregular menstruation, persistent pelvic pain, and secondary amenorrhea. In comparison with previously published cases, our findings align with reports from Nigeria, India, and South Africa, where women frequently present with chronic pelvic pain, secondary amenorrhea, and infertility. Diagnosis of FG‐TB is challenging due to its paucibacillary nature of genital lesions. Although microscopy and culture are still considered gold standards, their low sensitivity calls for a multimodal strategy that includes genetic methods, hysteroscopy, clinical assessment, and histopathology [5]. Unlike some cases in which pelvic ultrasound or hysterosalpingography detect abnormalities, our patient's unremarkable ultrasound corresponds with literature noting that early FG‐TB may present with normal imaging despite advanced endometrial disease. Histologically, the necrotizing granulomas seen in this case are similar to those reported by Mohakul et al. and Melkamu et al.; however, this case stands out in the literature due to the vast cotton‐like necrotic tissue seen hysteroscopically. Molecular tests like GeneXpert MTB/RIF have improved TB diagnosis worldwide, although they are not very useful in FG‐TB [7]. Despite obvious hysteroscopic and histological evidence of FG‐TB, a significant feature of this case is the negative GeneXpert MTB/RIF result. This is consistent with the findings from Sharma et al. showing low sensitivity of GeneXpert in genital specimens, underscoring the importance of correlating molecular testing with histology and hysteroscopy. This result emphasizes the well‐known limits of molecular assays for the diagnosis of extrapulmonary tuberculosis, especially in the vaginal tract. With a very low bacterial burden in endometrial or tubal tissue, FG‐TB is usually a paucibacillary variant of tuberculosis [6]. GeneXpert requires a minimal amount of mycobacterial DNA for detection, despite its great sensitivity for pulmonary tuberculosis. As a result, genital specimens frequently yield false‐negative results. The uneven distribution of lesions in the reproductive tract exacerbates this; biopsy samples may overlook regions that contain bacilli, particularly in cases where fibrosis or adhesions have warped normal structure [8]. Furthermore, granulomatous inflammation and scarring without active bacillary shedding are common outcomes of chronic illness, which further lowers GeneXpert positivity. These limitations highlight the fact that a negative GeneXpert test does not rule out FG‐TB, underscoring the significance of comparing clinical findings with histopathology and hysteroscopic characteristics, particularly in TB‐endemic locations [9]. Anti‐tuberculous therapy (ATT) remains the standard treatment. Most patients experience symptomatic improvement following therapy [7]. Repeat hysteroscopy in our patient showed that necrotic tissue and cervical inflammation had significantly resolved and follow‐up histology verified that there were no granuloma. The timing and frequency of follow‐up genital examination in FG‐TB was guided by treatment duration, clinical response, and the patient's reproductive goals. Current evidence supports a two‐stage endoscopic approach: an initial hysteroscopy at diagnosis and a repeat hysteroscopy with histological sampling upon completion of the full anti‐tuberculosis regimen typically at six to nine months. Diagnostic laparoscopy and hysteroscopy are performed at the beginning to diagnose the disease and subsequently after completion of full anti‐tuberculosis treatment to prognosticate the patient and to plan further management of infertility [6]. Studies using hysteroscopy after anti‐tuberculosis therapy have demonstrated decreased distortion of the uterine cavity and reduced prevalence of early‐stage adhesions, while more advanced adhesions tend to persist [1]. This is consistent with the findings in our patient, where necrotic tissue and cervical inflammation resolved on repeat hysteroscopy at eight months, while bilateral tubal obstruction and peripheral intrauterine adhesions persisted. Follow‐up histology confirming atrophic glands and stromal fibrosis without granulomas provided corroborating evidence of microbiological cure. Hysteroscopy can be utilized as a diagnostic tool for endometrial sampling, to evaluate the intracavitary condition after treatment, and as a prognostic tool for future reproductive function [7]. In line with recovery patterns observed following prompt anti‐tuberculosis therapy, intermittent vaginal spotting during therapy may indicate a partial restoration of endometrial function. However, restoration of fertility is less predictable. Even after microbiological cure, conception rates remain low due to irreversible tubal damage, endometrial fibrosis, and intrauterine adhesions [10]. Women affected by FG‐TB are also at increased risk of ectopic pregnancy and miscarriage. Though results are frequently less than ideal when endometrial involvement is extensive, assisted reproductive technologies (ART) may offer a path to conception [11]. This case highlights the importance of considering female genital tuberculosis in the differential diagnosis of infertility in high‐burden settings. The diagnosis was supported by the pattern of necrotizing granulomatous inflammation on histopathology, the history of close contact with a patient with pulmonary tuberculosis, and the favorable response to anti‐tuberculosis therapy. Alternative causes of granulomatous endometritis, including sarcoidosis, fungal infections, and foreign body reaction, were considered but excluded on the basis of the clinical context and microbiological findings. Sputum GeneXpert and chest radiography were not performed as the patient had no prior history of pulmonary tuberculosis and presented with no respiratory symptoms, including no cough, hemoptysis, dyspnea, or chest pain, providing no clinical indication for pulmonary investigation. Female Genital Tuberculosis can arise de novo from hematogenous dissemination of Mycobacterium tuberculosis without a clinically apparent or previously documented pulmonary source, and the diagnosis in this case was conclusively established through histopathological means. Early detection and treatment are critical to preventing irreversible reproductive tract damage. Early detection and treatment should be made easier by raising physician awareness, expanding diagnostic availability, and including tuberculosis screening into infertility assessments and reproductive health initiatives. The principal teaching message of this case is clear: clinicians in tuberculosis‐endemic regions must maintain a high index of suspicion for female genital tuberculosis in all women of reproductive age presenting with unexplained infertility, amenorrhea, or chronic pelvic pain. A multimodal diagnostic approach combining hysteroscopy and histopathology is essential, particularly when molecular assays yield negative results, and early treatment with anti‐tuberculosis therapy offers the best chance of limiting irreversible reproductive tract damage. Conclusion FG‐TB poses significant diagnostic and treatment hurdles and is a significant but frequently disregarded cause of infertility. To maximize the results for impacted women, multidisciplinary evaluation, enhanced diagnostic techniques, and more robust public health programs are crucial. Author Contributions Anthony K. Dah: conceptualization, data curation, formal analysis, investigation, methodology, writing – original draft, writing – review and editing. Dennis Brempong: data curation, formal analysis, methodology, writing – original draft, writing – review and editing. Paschal K. Dah: writing – original draft, writing – review and editing. Gladys Kaba: writing – review and editing. Emily Boakye‐Yiadom: writing – review and editing. Ernest Kwasi Adjei: formal analysis, investigation, resources. Verner N. Orish: writing – review and editing. Funding The authors have nothing to report. Ethics Statement Standard hospital‐based verbal and written informed consents were taken before pelvic examination and the hysteroscopy procedure respectively. Additionally, ethical clearance for this case report was obtained from the UHAS Review Ethics Committee (UHAS REC A.2 [23]24–25). Permission to access the patient's records was sought from the management of Supercare Specialist Medical & Ho Fertility Centre Ltd. Written informed consent was obtained from the participant before the data was accessed for the study. Confidentiality of the participant and her data was ensured by avoiding the use of the participant's names and identifiable pictures. Conflicts of Interest The authors declare no conflicts of interest. Acknowledgments Authors are grateful to the management and staff of Supercare Specialist Medical & Ho Fertility Centre Ltd. in Volta Region, Ghana. The authors are also very grateful to the patient for giving her consent to conduct this study. Data Availability Statement No Data are available. References Associated Data Data Availability Statement No Data are available.